Penumbra Overview
Latest P/E ratio for Penumbra: 78.53 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow78.53
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, PEN shows a P/E ratio of 78.53. That is above the Healthcare sector average of 27.42. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 27.42. Penumbra is at 78.53, which is higher that average. That is roughly 186.4% above the sector mean. Use the comparison chart on this page to see how PEN stacks up against individual peers as well.
Investors watch PEN's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Penumbra's latest reading is 78.53. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Penumbra's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 78.53) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 27.42, while PEN is at 78.53. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
